-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: biotechnology
BIOtechNOW: Where the biotech industry meets online
As the biotech industry prepares to meet at the 2011 BIO International Convention in Washington, DC next week, I’m pleased to announce that we’ve re-launched BIOtechNOW as a multi-blog platform. Our new platform aims to create an online biotech community where we can connect to discuss the latest industry news – kind of like our convention, but available online 365 days a year. BIOtechNOW will be a critical component of our advocacy, education and business Read More >
Joint Statement of BIO, AAU, ACE, APLU, AUTM and COGR
Earlier today, the United States Supreme Court issued its opinion in the appeal of Stanford University against Roche Diagnostics. This case is of significant interest to the Biotechnology Industry Organization (BIO), Association of American Universities (AAU), American Council on Education (ACE), Association of Public and Land-grant Universities (APLU), Association of University Technology Managers (AUTM), and Council on Governmental Relations (COGR) because of its potential impact on university technology transfer, on development and commercialization of university-generated Read More >
USPTO Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting
Biotechnology/Chemical/Pharmaceutical Customer Partnership Wednesday, June 8, 2011 Meeting Madison Auditorium Starting Time of 10:00 AM United States Patent and Trademark Office Alexandria, Virginia 600 Dulany Street, Alexandria, VA, Accessing the event: Double click on the link below (or copy it into your internet browser) https://uspto.connectsolutions.com/r80345544/ Click here for detailed login instructions in MS Word. Driving & Metro Directions /Hotels (Word) Campus Map (html) Campus Map (Power Point) Morning Session 10:00 – 10:30 AM. Greetings, TC Update Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: BCP, biotechnology, Biotechnology Chemical Pharmaceutical Customer Partnership Meeting, Clearing the Oldest Patent Applications (COPA), Expedited Examinations, Green Tech, Microsoft v. i4i Ltd., Patent Prosecution Highway, Plant Utility Patents, Track 1, USPTO
Tags: BCP, biotechnology, Biotechnology Chemical Pharmaceutical Customer Partnership Meeting, Clearing the Oldest Patent Applications (COPA), Expedited Examinations, Green Tech, Microsoft v. i4i Ltd., Patent Prosecution Highway, Plant Utility Patents, Track 1, USPTO
Beware the Liability Gaps in Biotechnology M&As
Mike Yeager, Senior Underwriting Specialist, Chubb Mergers and acquisitions continue to be a source of growth for the biotechnology industry. Even the financial crisis has not significantly slowed this trend. In fact, a weakened global economy may have further fueled consolidation as biotechnology companies sought additional efficiencies in R&D, procurement or administration. Since many biotechnology companies have complex corporate structures—some with hundreds of subsidiaries—executives at acquiring companies recognize that along with the benefits of the Read More >
BIO World Congress Begins with Newsmakers
BIO’s 2011 World Congress got off to a strong start in Toronto, with news announcements from G2 BioChem and others throughout the morning. The big news from BIO was the presentation of the George Washington Carver Award to Royal DSM CEO/Chairman Feike Sijbesma. Sijbesma discussed the evolution of DSM from a coal mining company to a chemical company and now to a global life sciences and materials company. For Sijbesma, this transformation mirrors the current Read More >
